Brief: Kinnate Biopharma Closes $35 Mln Series A Financing To Establish A Chinese Joint Venture
13/05/2021 22:33
May 13 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. CLOSES $35 MILLION SERIES A
FINANCING TO
ESTABLISH A CHINESE JOINT VENTURE
* KINNATE BIOPHARMA - SERIES A FINANCING LED BY ORBIMED ASIA
PARTNERS, WITH PARTICIPATION FROM ORBIMED PRIVATE INVESTMENTS &
FORESITE CAPITAL
Source text for Eikon: ID:nGNX1zRN29
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview